Ed Seto

2.5k total citations · 1 hit paper
9 papers, 1.9k citations indexed

About

Ed Seto is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ed Seto has authored 9 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Ed Seto's work include Histone Deacetylase Inhibitors Research (5 papers), Ubiquitin and proteasome pathways (3 papers) and Epigenetics and DNA Methylation (3 papers). Ed Seto is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Ubiquitin and proteasome pathways (3 papers) and Epigenetics and DNA Methylation (3 papers). Ed Seto collaborates with scholars based in United States, China and Japan. Ed Seto's co-authors include Minoru Yoshida, Lihong Chen, Jiandong Chen, Alexey V. Ivanov, Frank J. Rauscher, Chuangui Wang, William J. Fredericks, György Fejér, Ildikó Győry and Nilanjan Ghosh and has published in prestigious journals such as The EMBO Journal, The Journal of Immunology and Cancer Research.

In The Last Decade

Ed Seto

9 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Erasers of Histone Acetylation: The Histone Deacetylase Enzymes

2014 1.5k citations Ed Seto, Minoru Yoshida Cold Spring Harbor Perspectives in Biology profile →

Peers

Countries citing papers authored by Ed Seto

Since Specialization

Citations

This map shows the geographic impact of Ed Seto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Seto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Seto more than expected).

Fields of papers citing papers by Ed Seto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Seto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Seto. The network helps show where Ed Seto may publish in the future.

Co-authorship network of co-authors of Ed Seto

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Seto. A scholar is included among the top collaborators of Ed Seto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Seto. Ed Seto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology 2017 ·Journal of Leukocyte Biology ·Eva Sahakian, Jie Chen, John J. Powers, Xianghong Chen, (unknown), Susan Deng, (unknown), Maritza Lienlaf, Hongwei Wang, Fengdong Cheng, Andressa L. Sodré, Allison Distler, Limin Xing, Patricio Perez-Villarroel, Sheng Wei, Alejandro Villagra, Ed Seto, Eduardo M. Sotomayor, Pedro Horna, Javier Pinilla‐Ibarz	48
2	Abstract 2331: HDAC6, new role as master regulator of PD-L1 and immune-related pathways 2016 ·Cancer Research ·Tessa Knox, Maritza Lienlaf, Patricio Pérez, Mibel Pabon, Calvin Lee, Fengdong Cheng, Eva Sahakian, John J. Powers, Susan Deng, (unknown), Alan P. Kozikowski, (unknown), Amod Sarnaik, Ed Seto, Jeffrey S. Weber, Eduardo M. Sotomayor, (unknown)	1
3	The Tumor Suppressive Effects of HPP1 Are Mediated Through JAK-STAT-Interferon Signaling Pathways 2015 ·DNA and Cell Biology ·Jonathan M. Hernandez, Abul Elahi, W. Edwin Clark, Leigh Ann Humphries, Jian Wang, (unknown), Ed Seto, David Shibata	10
4	Erasers of Histone Acetylation: The Histone Deacetylase Enzymes breakdown → 2014 ·Cold Spring Harbor Perspectives in Biology ·Ed Seto, Minoru Yoshida	1511
5	Abstract 4089: Histone deacetylase 6 (HDAC6) as a regulator of PD-L1 expression through STAT3 modulation in melanoma 2014 ·Cancer Research ·Maritza Lienlaf, Patricio Perez-Villarroel, Calvin Lee, Fengdong Cheng, (unknown), Tessa Knox, (unknown), Amod A. Sarnaik, Pedro Horna, Ed Seto, (unknown), Jeffrey S. Weber, Eduardo M. Sotomayor, (unknown)	1
6	Acetylation and deacetylation of non‐histone proteins 2006 ·The FASEB Journal ·Ed Seto, (unknown), Mary Zhang, Michele A. Glozak, Nilanjan Sengupta, (unknown), Philip G. Wong, Bernadette Ferraro, Natalie Rezai‐Zadeh	15
7	Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites 2006 ·Biochemical Journal ·Bharat Joshi, S. Rastogi, Mark Morris, (unknown), (unknown), Ed Seto, Srikumar Chellappan	48
8	MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation 2005 ·The EMBO Journal ·Chuangui Wang, Alexey V. Ivanov, Lihong Chen, William J. Fredericks, Ed Seto, Frank J. Rauscher, Jiandong Chen	206
9	Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines 2003 ·The Journal of Immunology ·Ildikó Győry, György Fejér, Nilanjan Ghosh, Ed Seto, Kenneth L. Wright	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact